Cargando…
Advances in orphan drug development: Time to change the status and stereotype
Rare diseases remain a challenge for many of the countries in the world. The millions of people collectively suffering from rare diseases, in the context of raging COVID-19 pandemics globally, require an innovative and recent solution from different stakeholders. Regulatory bodies such as the Food a...
Autor principal: | Thakur, Sayanta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345260/ https://www.ncbi.nlm.nih.gov/pubmed/35928643 http://dx.doi.org/10.4103/picr.picr_193_21 |
Ejemplares similares
-
Advances in Vasodilatory Shock: A Concise Review
por: Lahiry, Sandeep, et al.
Publicado: (2019) -
Orphan drug: Development trends and strategies
por: Sharma, Aarti, et al.
Publicado: (2010) -
Current status and trend of clinical development of orphan drugs in China
por: Xiang, Ziling, et al.
Publicado: (2022) -
Estimating the clinical cost of drug development for orphan versus non-orphan drugs
por: Jayasundara, Kavisha, et al.
Publicado: (2019) -
Challenges in orphan drug development and regulatory policy in China
por: Cheng, Alice, et al.
Publicado: (2017)